Key result
Hypertrophic obstructive cardiomyopathy is associated with an estimated annual death rate of ~2% and a 4-fold greater risk of stroke compared to non-obstructive hypertrophic cardiomyopathy (~1%/year).
Population
Patients with hypertrophic cardiomyopathy (HCM) and hypertrophic obstructive cardiomyopathy (HOCM)
Design
Review
Authors
Loading...
May warrant intensified stroke risk assessment in obstructive HCM; leaves open whether obstruction relief improves survival.
Hypertrophic obstructive cardiomyopathy carries a higher annual death rate and a 4-fold greater risk of stroke compared to non-obstructive hypertrophic cardiomyopathy.
Roberts et al. (2005) conducted a review in Hypertrophic cardiomyopathy. Hypertrophic obstructive cardiomyopathy is associated with an estimated annual death rate of ~2% and a 4-fold greater risk of stroke compared to non-obstructive hypertrophic cardiomyopathy (~1%/year).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: